Hepatocyte growth factor (HGF) is essential for injuryr epair.D espite high HGF levels in chronic ulcers, up-regulation of HGF receptor in ulcer tissue and decreased biological activity of HGF in ulcer secretions havebeen observed. With asurface plasmon resonance-based method, we assessed the binding of HGF to antibodies, receptors, and the basement membrane and identified binding interactions that are indispensable for the biological activity of HGF.Recombinant HGF (rHGF) lots were tested for activity,s tructural integrity,a nd degradation, and the results were verified in an in vitro model of cell injury. Biologically activerHGF,aswell as plasma from healthy volunteers, bound to heparan sulphate proteoglycan (HSPG) and to anti-HGF antibodies. Decreased binding to HSPG was the first event in rHGF degradation. This study established the feasibility of identifying patients with chronic inflammation who need exogenous HGF and of using ligand-binding assessment to evaluate rHGF lots for biological activity.
Introduction
Hepatocyte growth factor (HGF)i sapotent growth stimulator of mature epithelial cellst hat plays an important role in regeneration and repairafter injuries (Matsumoto and Nakamura 1991) .Natural HGF is a heterodimeric protein of 96 -110 kDat hat consists of one a chain (67 kDa) and one b chain (35 kDa; Godha et al. 1988) . Mesenchymalc ells produceH GF as a single-chain precursor (Arakakie ta l. 1995),w hichi s activated by the proteolytic function of HGF activator (Miyazawa et al. 1993) .T he HGF receptor, protooncogene c-Met, is at ransmembrane protein expressed on epithelial cells ( Prat et al. 1991) .I n addition, at least two binding sites for HGF on rat liver cell surfaces have been identified: ah igh-affinity c-Met/HGF receptor andaheparan sulphate proteoglycan (HSPG) binding site (Liu et al. 1992 ).
Basementm embranes support epithelial ande ndothelialcells,prevent thepassage of proteins,and generate histologicallydistinctc ompartments in theb ody. These membranesc ontain threem ajor components: collagen IV,laminin, andHSPG, allofwhich arelocalized to the basallaminaportion of basement membranes. HSPGis as ulphatedg lycoproteint hatb inds andf acilitates the cytokine-receptori nteraction ( Rescan et al.1 993) and thec onversiono fp romitogen HGFt ot he two-chain form (Liu et al. 1992 ) High levels of HGFh ave been reported in bloodduringacute injuriessuchasinfectious diseases (Nayeri et al. 2002c) . HGFisalso produced and released locallyinaparacrinefashion at thesite of acute injury (Nayeri et al. 2000 (Nayeri et al. , 2002b .
Surface plasmonr esonance (SPR) is an optical technique that can simultaneously determine the affinityo faprotein for several ligands by using individual surfaceso nt he sensor chip (Liedberg and Johansen 1998; Nayerie ta l. 2005a) . SPR enables rapid analyte detection in real time without any labelling of samplesand can be used for concentration determination, kinetic studies, and epitope mapping. The sensor surface of the SPR apparatus consists of a carboxymethylated dextran matrix, whichi sahydrogel that provides as olution-like environment for the biospecific interactions. The carboxyl groups in the dextranmatrix enable the covalent couplingofligands (proteins, receptors, DNA,etc.) to the surface.Upon testing several ligands that might bind HGF,wefound at leastf ourl igands that were importantf or distinguishing between different lots of rHGFo r endogenous HGF (Nayeri et al. 2004 (Nayeri et al. , 2007 . This difference might havebiological consequences such as in the healing of ulcers (Nayerieta l. 2002d) .
ELISAisareliable,sensitive method forthe detection of proteins in samples. Since1998, we have determined thec oncentration of HGFi nd ifferent recombinant batcheso rb lood by usingacommercial ELISAk it (R&D,M inneapolis,M N, USA),b ut we couldn ot ascertaint he epitopea gainst whicht he monoclonal antibody in thek it wasp roduced. However, we have obtained reproducible resultswiththe HGFELISA kit in severalstudies (Nayeri et al.2000 (Nayeri et al. , 2002b .Whilst studying differentlotsofrHGFbyELISA,weobserved that theconcentration of rHGF in reconstitutedsamples correlated with thee xpectedc oncentration.H owever, we didn ot findd ifferences betweenb iologicallyactive andinactivelotsbyELISA (Nayeri et al.2004 ).Thus, thecommercialELISA kitdeterminedthe totalamount of HGFbut provided no informationabout thequality or activity.I narecent study, we showed that patients with chronicu lcersh ad HGFw ithd ecreased activity compared to patients with acuteu lcers (Nayeri et al. 2004) . This observationled us to investigatethe quality of HGFb othe ndogenouslya nd in exogenousl otsi n in vivo (Nayeri et al.2007 ) and in vitro contexts.
In thep resent work,w ei ntroduce an SPR-based method to evaluatethe qualityand biological activityof rHGF accordingt ot he relative binding response of the cytokinet oanumber of biologically relevant ligands. Theresults obtained by this method correlated with high sensitivitya nd specificity to ther esultso fabiological assayi nt he CCL-53.1 cell line, whichr esponded specifically to HGF ( Nayeri et al. 2007 ).T he predominantb inding response in biologically active HGFwas identified.W ealso show that systemic HGFin theb lood of patients with chronic legu lcersh ad decreased quality comparedwiththatofhealthy controls.
Materials and methods

Patients
Ve nousb lood was gathered from 16 patients with chronic leg ulcers( age range, 42 -87y ears; median age, 77 years; 4m en). Some of these patientsw ere included in previouss tudies (Nayerie ta l. 2004 (Nayerie ta l. , 2005b . The plasma was separated and keptfrozen at 2 708 Cp endinganalysis.
Ulcer secretions
Ulcers ecretions were obtained from 10 patients with chronic legu lcersa nd from 5p atientsw ith acute ulcers. This material was used in previousstudies from our group (Nayerieta l. 2004 (Nayerieta l. , 2005b .
Healthy controls
Plasmawas obtained from 20 people(agerange, 34 -83 years; median age, 55 years; 10 men) without any signs of infection andw ith no history of chronic leg ulcersand kept frozen.
Recombinant human hepatocyte growth factor
Recombinant hHGF wasagift from Professor Nakamura, Osaka, Japan (2002) . HGF was also obtained commercially (10 lots from R&D Systems, expressed in Sf 21 insect cells and in mouse myeloma cell line NSO; 3l ots from Sigma Aldrich, St Louis, MO,U SA; 1l ot from Santa Cruz Inc., SantaC ruz, CA, USA; and 1l ot from GenWay Biotech Inc., San Diego, CA, USA).
Buffyc oat
Abloodsamplewas obtained by venous puncture from a healthyblood donor, a59-year-old man. Thebuffy coat wasd ivided into twop arts.T he firstp ortion was centrifuged at 3000 g for2 0min,a nd thes upernatant wascollected.The other part wasfrozenat 2 708 Cfor 1h to haemolyse theb lood cells,t hawed, and centrifuged at 3000 g for2 0min,a nd thes upernatant wascollected.Fromthe same individual,abloodsample wasgatheredinatube (VENOJECT w silicone-coated) andcentrifuged at 3000g for20min to collectthe serum. Amounts( ELISA) andb inding character( Biacore) of HGFi nt he buffyc oatb eforea nd afterh aemolysisa s well as in theserum were determined.
Endogenous HGF
Venous blood from ah ealthy 55-year-old man was gathered in steriles ilicone-coatedt ubes (VEN-OJECT w )a nd placed at room temperature for 1h. The liquid on top of the coagulated blood was gathered and addedt oK aighn'sm odification of Ham'sF -12K medium (ATCC) supplemented with 10% foetal bovine serum (Sigma-Aldrich, Stockholm, Sweden) in an atmosphere of 5% CO 2 and 95% air at 378 C. After 48 h, the medium was centrifugeda t 3000g for 20 min, and the supernatant was collected and kept frozen at 2 708 C.
Evaluation of biological activity of HGFinamodelofcell injury
Thebiological activity of HGFinsamples wastestedin an in vitro cell injury assayusing transformedmouse skin epithelial cells( CCL-53.1 cell line). Them ethodi s described in apreviouspublication (Nayeri et al.2007 ). CCl-53.1 cellsweregrown in Kaighn's modificationof Ham'sF -12K medium (ATCC) supplemented with 15%horse serumand 2.5% foetal bovine serum(SigmaAldrich)i na natmosphereo f5 %C O 2 and9 5% aira t 378 C. Aftert he cellsr eached confluence, they were separatedwithnon-enzymatic cell dissociation solution (1 £ )( Sigma-Aldrich),s uspended in F-12K medium with 15%h orse serumand 2.5% foetal bovine serum, andinoculatedona24-wellculture plate(Nunc Brand Products,R oskilde, Denmark).C ells were cultured undert he same conditions for2 4-48h untilt hey reachedconfluence.Then, theconfluentmonolayer was scrapedwithasterile steeldevice. Detached cellswere washed with PBS, andfresh medium wasadded to the wells. Theareaofthe square notcoveredbycells (mm 2 ) wasm easured by microscopy (Olympus)a nd documented in each well.HGF wasadded,and thecells were incubatedat37 8 Cinahumidifiedatmospherecontaining5%CO 2 .After 24 and48h,the area notcovered by a monolayerwas measured againand documented.
Ligands
Biologically relevant ligands of HGF [monoclonal anti-HGFa ntibody( unknown epitope), polyclonal antibodies against different parts of HGF,a nd HGF receptors] were obtained commercially (Table I) and immobilised on Biacore CM5 chips.
SPR measurementsand ligand immobilisation procedures
SPR measurements were conducted at 760 nm in a fully automatic Biacore 2000 instrument (GE-Healthcare GmbH,U ppsala, Sweden) equippedw ith four flow cells. The flow cell temperature was 258 Ci na ll experiments. Thes amples urfacesw ere carboxymethylated dextranC M5 chips( GE-Healthcare GmbH). Couplingo fl igands to the carboxylic acid groups of the dextran hydrogel was carried out by conventional carbodiimide chemistryu sing 200 mM N -ethyl-N 0 -(3-diethylaminopropyl)c arbodiimide (EDC) and 50 mM N -hydroxysuccinimide (NHS). The activation time was 7min, followed by a7 -min ligandi njection. Deactivation of the remaining active esters wasp erformed by a7 -mini njection of ethanolamine/hydrochloride at pH 8.5. Aflow rate of 5 m l/min was usedduring immobilisation.
Theligands (Table I) were dilutedin10mMacetate buffer at apHbelow theprotein's isoelectricpoint,thus enhancingt he electrostatici nteractionsb etween the dextranm atrixa nd thel igands.T he contactt imew as 7min,w hich resulted in levels of immobilisation between8 000a nd 30,000 response units( RU). After deactivation, the surfaces were washed with five subsequent 1-mini njectionso f5mM glycineb uffer, pH 2.0, with 1M NaCl (regenerationb uffer).O ne of theflow cellswas used to monitort he response dueto interactiono fH GF with thec arboxymethylated dextranm atrix. This flowc ellwas treatedi nt he same wayasthe othersduringthe immobilisation procedure, butthe ligand immobilisation step wasomitted. Lyophilised rHGF was reconstituted and analysed at different concentrations. Sodium chloride (9 mg/ml, B. Braun Medical AB, Bromma, Sweden), distilled water( B. Braun MedicalA B),p hosphateb uffer solution (pH 7.4, Apoteket AB, Umeå ,Sweden), and HBS-EP (0.01 MH EPES, pH 7.4, 0.15 MN aCl, 3mME DTA, 0.005% surfactant P20) (GE-Healthcare GmbH)w ere used as dilutionb uffers.A1:1 mixture of 1M NaCl þ 10 mM glycine,p H2 ,w as used as aregeneration buffer.
The blood sampleswere diluted 1:20 in phosphate buffer solution (pH 7.4, Apoteket AB). One injection of 1:1 1M NaCl:10 mM glycine,p H2 ,f ollowed by one injection of borate 8.5 was used as aregeneration buffer for the blood samples. Legulcer secretions were diluted 1:10 in phosphate buffer solution. To avoid the effects of degrading enzymes, ap rotease inhibitor (1 -5%) [4-(2-aminoethyl) benzenesulphonyl fluoride (AEBSF), pepstatin A, E-64, bestatin, leupeptin, and aprotinin (but no metal chelators); Sigma Aldrich] that specifically inhibited serine, cysteine, and aspartic proteases and aminopeptidasesw as added to the leg ulcer secretion 7-10 min prior to analysis. A1 :1 mixture of 1M NaCl þ 10 mM glycine,p H2 ,w as used as ar egeneration buffer.
The presented SPR data were extracted from the Biacore sensorgrams after the injections were finished, i.e. during the analyte dissociation phase. One Biacore RU corresponds to as urface concentration of 1pg protein per mm 2 (Stenberg et al. 1991) .T he binding of HGF to ligands was tested in fresh samplesa fter reconstitution.The effectoftime on the response was tested by continuous analysis of binding over time on the same chip and during the same run. The ligand binding of HGF after incubation at room temperature for 15 hwas comparedwith ligandbinding of afreezethawed sample. In addition, the effect of intracellular degrading enzymes on the binding of HGF to ligands was tested in buffy coat before and after haemolysis. Apositive control was includedatthe beginning and at the end of each runt oc onfirm the reliabilityo f surfacesafter several regeneration buffer injections.
ELISA
Ac ommercial ELISA kit (Quantikine Human HGF 96 tests, R&D Systems) was used to determine the concentrationofHGF in samples. Our grouphas used this method since 1996, and the samep erson has performed all tests to reduce the inter-and intra-assay errors (Nayerieta l. 2000 (Nayerieta l. , 2002b .
Statistics
Parametric( ANOVA)a sw ella sn on-parametric (Mann -Whitney U test, Spearman's regression test) (Statistica) tests were used for statisticalanalyses, and p , 0.05 was considereds tatistically significant.
Results and discussion
The following procedures were repeated several times with different lots and had reproducible outcomes. Representative data are reported. The rHGF obtained as ag iftf romP rofessorN akamura2 002w as biologically active andw as SPRr esponsive( see below) andw as used as positive control in some of the experiments. However in the reportedr esults HGF produced by leukocytes in ah ealthy volunteer was used as ap ositive control.
rHGF
Responsive lots.T he rHGF lots that bound to all ligands (Tables Iand II) with approximately the same absolute RU values(termed "SPR responsive") had a motogenic effecto nC CL-53.1 cells in the in vitro model of cell injury(. 95% sensitivity and specificity). We showed previously (Nayerie ta l. 2007) that the biologically active rHGF lots had motogenic effects on CCL-53.1 cells; therefore, the SPR responsive lots were consideredb iologically active (Table II) . To simplify the calculation, we used the ratio of the binding responses to HSPG and to MN.B iological activity was observedi nH GF lots in which the HSPG/MN ratio was $ 0.3. However, the cut-off ratio might be different in serum or plasma.
In SPRresponsivesamples,there wasapositive and significant correlation betweenH GF amount ( m g/ml) andt he SPRr esponse to epitopes ( r 2 ¼ 0.97, p , 0.0001).AsshowninT able III, thebinding signals form onoclonala nti-HGF( MN)a nd polyclonal anti-HGF(PK)decreased with dilution of therHGFsample. Asimilar finding wasobtainedwhenweanalysedHGF in faecesf romp atientsw ith acutei nfectiousg astroenteritis (Nayeri et al.2005a Binding of HGF to HSPG/dextran sulphate (DS) proved to be important for the biological activity of HGF.T he addition of DS or HSPG to the samples reduced the binding (i.e.d ecreased the response) of HGF to the ligands (Figure 1) , as well as decreased the biological activity of HGF.This observation is similar to the results obtained from analysis of HGF in the faeces of patientswith acutei nfectious gastroenteritis (Nayerie ta l. 2005a), in which the binding signalt o HGF ligands in SPR decreased significantly after the additiono fD St ot he samples. The decrease in binding signalm ight implyt hat the dextran-binding siteo fH GF overlaps with the antibody-binding epitope,o rt hat dextran binding induces ac onformationalchangei nt he HGF molecule.
In common with many other growth factors(e.g. the fibroblastg rowth factor family and vascular endothelial growth factor),H GF displays as trong affinity for heparin, and this proved to be au seful aid in its purification ( Nakamura et al.1 986) .H eparan sulphate (HS) is widely expressed, in the formo f variousp roteoglycan species,o nt he surfaces of most cells andi ss ecreted directly into the extracellular matrix (Nakamura et al. 1986 ).L yone ta l. (1994) demonstrated by affinity chromatography that HGF interacted with HSPG under physiological conditions of pH and ionic strength. This interaction appearedto be mediateds olely by the HS chains and was of comparable affinity to the interaction of HGF with heparin. In addition, heparin competitively inhibited the binding of HGF to HSPG. These results indicate that the primaryHS-binding site, and perhaps also the heparin-binding site, is presentonthe a -chain of HGF (Gallagher 1989) . The HGF-binding site is present withint he iduronate-and sulphate-richd omains of HS, and its structure has beenp artially elucidated (Gallagher 1989) . The interaction of HSPG with HGF seems to be mediated primarily by the HS chainsand not the protein core. Figure 1s hows that theb inding of HGFt o antibodies raised against the N-terminuso fH GFb (N19),the N-terminusofHGFa (N17), amino acids 32 -176 of HGFa (H145), and an internal region of HGF b (D19) mightc orrelate with the dextranbinding affinity of HGF.T he present work does not address the mechanismo ft he difference between biologically active and inactive HGF with regard to the binding affinity to these epitopes. However, previous studiesh aveh ighlighted the role of HGFb in the biological activity of HGF.S tamos et al. (2004) Ta ble III. SPR response (RU) and biological activity of samples containing HGF. The immobilisation levels for ligands are given in parentheses. The same chip was used for all measurements. Biologically active endogenous HGF was used as ap ositivec ontrol. The rHGF GJ175031 þ PK as well as the biologically inactiver HGF lot GJ1750031 (Nayeri et al. 2005b ) at different dilutions wereused as negativecontrols.Because rHGF GJ175031 had binding affinity to all of the ligands in the study,this lot was termed "SPR responsive."The biological activity was determined by measurement of the nude area after addition of rHGF to injured CCL-53.1 cells.The motogen activity of biologically activeHGF causes migration of nearby cells towards the injured area and asubsequent decrease in nude area size (Nayeri et al. 2007 ). The biologically inactiver HGF QF031062 had no affinity to the ligands at different concentrationsa nd was therefore "SPR non-responsive." Figure 1 . Effect of the addition of 10% DS (10 mg/ml in MQ water) to an rHGF lot (diluted in PBS) on the SPR binding response to different HGF ligands.
showed that the HGF b -chain alone bindsc-Met and reportedt he crystal structure of HGFb in complex with the Sema and PSI domains of the c-Metreceptor. The c-Met Semadomain folds intoaseven-bladed bpropeller in whichthe bottom faces of blades 2and 3 bind to theH GF b chain "active site region". Mutation of HGF residues in the area that correspondsw ith the active site region in related serine proteases significantly impairedH GFb binding to cMet. Lokker et al. (1992) r eported that an HGF variantw ith mutations at residues Y673 and V692, whichare located in the active site region of the HGF b -chain,had binding affinityfor c-Met in the context of two-chain HGF but had significantly impaired biological activity.Inaprevious study,weshowed that after the binding of HGF from conditioned medium of injuredk eratinocytest ot he c-Metr eceptor, the affinityo fH GF for the H-145 antibody (Table I) decreased, which might indicate that the H-145 epitope is involved in HGF interaction with the c-Met receptor (Nayerie ta l. 2006).F urther studies are planned to investigate the underlying mechanisms for these observations.
Non-responsive lots.T he lots of rHGF thats howed no binding to any of the ligands or that bound MN (Table I) but displayed much lower binding of HSPG had no biological activity in the CCL-53.1 cell line (Nayerie ta l. 2007) and were therefore regarded as biologically inactive (Table II) . Binding of HGF to HSPG is important to facilitate the contact between HGF and its receptor (Liu et al. 1992; Rescan et al. 1993) .T his factor might explain why the rHGF lots without affinity for HSPG and DS were biologically inactive. Furthermore, the SPR non-responsivel ots did not havet he same affinitiest oa ntibodiesd eveloped against HGF peptides (Table I ). In some lots there was ah igh affinity of HGF for MN (with unknown epitope,T able I) but am uchl ower affinityt oo ther surfaces (Figure 2) . In some lots therewas no affinity to surfaces at all (Table III) . As mentioned previously, the SPR responsive,b iologically active lots showed a binding response to all surfaces. We haven ot studied the underlying mechanisms for such differences in ligand-bindingp rofiles between SPR responsivea nd non-responsive lots. Further studies are planned to analyse the molecularb asis of these differences.
Time-related changes in binding.Byrepeated analysis of the binding responses of different HGF lots to surfaces with time, we observed that the freshly reconstituted rHGF lots from the same batch had asimilar binding response to ligands. However, this binding response decreased within minutes after reconstitution.T hus, we analysed theb inding response of oneS PR responsiveand one SPR non-responsive lot to ligands that might be importanti nd istinguishing the biologically active lots. As shown in Figure 2 , the non-responsive rHGF lot had an initially high affinity to MN but muchl ower affinity to D19 and HSPG. However, the binding response to MN decreased significantly over time.O nt he other hand, in a reconstituted SPR responsiverHGF lot, the binding of HGF to HSPG decreased as the first step in the process of inactivation(Ta ble IV). In another experiment, the binding of carrier-free HGF was betterpreservedafter 15 hatroom temperature than after thawing asample within1 5h of freezing( 2 208 C) and reconstitution (Table V) .A lthough these arep reliminary observations, the results might indicate that several freeze-thaw cycles are notbeneficial fort he biological activity of rHGF lots. Lyophilized rHGF (5 m g/ml) was reconstituted in PBS, pH 7.4, to 1ml(5000 ng/ml). 100 m lwas added to one tube containing 900 m l PBS and to two other tubes containing 890 m lPBS and 10 m lDSor MN to reach the dilution of 1:10 (500 ng/ml). HSPG was added to 100 m lun-dilutedrHGF (5000 ng/ml). The initial four samples were analyzed in one Biacore run. Dilution and running of the four samples took 1h.T he samples were kept at room temperature for 24 ha nd then re-analysedi nt he same chip.T he immobilisation levels (RU) are giveni nparentheses.
Assessment of quality.Byusing the SPR-based method, we observedd ifferences between HGF lots in the relativel igand-bindingr esponses that correlated significantly with their quality (Figure 3 ). Samples containing bacteria or chemical preparations,w hich are unsuitable for biological in vitro assays, could be evaluated for HGF quality by SPR. In somer HGF lots, the appropriate dilution of HGF to use in experimentsc ould be determined by analyzing different concentrationso fr HGF with the Biacore instrument and by choosing the concentration that gavethe most similar binding to all ligands (TableIII).
Buffy coat.rHGF lots were quiteunstable in the SPRbasedanalysis of HGF. However, ourprevious studies that analysedH GF in several patient groups ( Nayeri et al. 2000 ( Nayeri et al. , 2002b The results are obtained from Biacore runs performed on the same chip.T he immobilisation levels (RU) are mentioned in parentheses. same blooddonor were analysed andshowntobesimilar (Table V) .T hisr esultm ight indicate that serumi sa reliable source fora nalysiso fe ndogenousH GF.T he pellet that containedthe cellswas placed at 2 708 Cand then thawedtoinducehaemolysis. Theconcentration of HGFdeterminedbyELISA in thehaemolysedsample washigherthanthat in thenon-haemolysed buffycoat, butt he SPRr esponsef or alll igands in Biacoreh ad decreasedb y , 50%( Ta bleV I).T hisfi ndingm ight indicate degradation of HGFbyenzymes released after leukocyte lysis, whichr esultedi nahigh amount of biologically inactive HGF. Thus,SPR mightbeamore accurate indicatorofprotein qualitythanELISA.
Patients
The HGF binding profile in patients with chronic leg ulcerswas examined.W ehad observedpreviously that these patientshad high amounts of endogenous HGF in ulcer secretions but decreased biologicalactivity of HGF (from the sames ample)i nt he CCL-53.1 cell line (Nayerie ta l. 2004,2 007).T here wasn o significant correlation between age or sexo fp atients and healthy controls and the SPR response of HGF to the ligands.T he binding response of HGF in plasma and in the ulcer secretions of patients with chronic leg ulcers differeds ignificantly from that of healthy controls (Table VII) . Binding to ligands crucial for the biological activity of HGF( e.g. HSPG, N17 and N19) was decreased in the plasma from patients with chronic ulcerscompared with the plasma from healthy controls. However, direct biological activity of HGF was not observed upon adding whole blood, serum, or plasma to CCL-53.1 cells. The ratio of the binding response of HSPG/MN in leg ulcer secretions correlated significantly with the biological activity of HGF (Figure 4) . Therefore, patientsw ith chronic leg ulcerse xhibited ac hangei n the quality of HGF in the blood and decreased biological activityo fH GF in ulcer secretions. However, the mechanism behind the changed quality of HGF in the blood of patients with chronic leg ulcers is unclear. In some otherc hronici nflammatory diseases such as lungfi brosis, increased levels but decreasedb iologicala ctivityo fH GF have been reported (Yamanouchi et al. 1998; Marchand-Adam et al.2006) .Further studies are plannedtoinvestigate the mechanisms in patientswithc hronic leg ulcers.
Conclusion
SPR-based assessments of the binding profile of HGF to relevant ligands might rapidly ands ensitively distinguish HGF variants with biological activity. Appropriate for clinical studies, this methodmight be used for evaluation of the quality of endogenous HGF and for recognition of patients who might benefitfrom exogenous HGF treatment.
